India eases coronavirus restrictions even as cases surge
With shutdowns devastating a nation where millions were already barely surviving, one official says it's time to learn to "live with the virus."
Vaccine
Pentagon agency tasked with finding coronavirus antibodies
The Defense Advanced Research Projects Agency (DARPA), a stealthy Pentagon organization responsible for many technological breakthroughs, is rushing to find the three most potent antibodies to combat COVID-19. Catherine Herridge reports.
Gilead CEO says remdesivir could reach COVID-19 patients within days
Daniel O'Day said on "Face the Nation" that Gilead has donated its entire supply of remdesivir to be administered to hospitalized COVID-19 patients.
Transcript: Gilead CEO Daniel O'Day on "Face the Nation"
The following is a transcript of an interview with Gilead Sciences CEO Daniel O'Day that aired Sunday, May 3, 2020, on "Face the Nation."
Human trials begin for COVID-19 vaccine
Human trials for a coronavirus vaccine are underway in Britain after group of scientists at Oxford University developed a formula they believe could stop the deadly virus. CBS News foreign correspondent Imtiaz Tyab reports from London.
What to know about coronavirus immunity
A group of medical experts warn the coronavirus pandemic could last up to two years and won't be controlled until about two-thirds of the world's population is immune. Dr. Bob Lahita joined CBSN to discuss what we know about immunity in the battle against COVID-19.
Federal social distancing guidelines expire
The social distancing guidelines set out by the White House expire April 30, while stay-at-home orders are still in effect in many states. CBS News chief Washington correspondent Major Garrett joins CBSN to talk about the latest in the pandemic response and other political headlines.
Oxford scientists say they may have a vaccine ready by September
In the global race to find a vaccine, Oxford University just jumped way ahead of the pack.
Vaccine skeptics already casting doubt on one for COVID-19
Global health experts fear naysayers' misinformation could hinder efforts to stop the coronavirus once a vaccine is developed
Trump says coronavirus "is going to go away"
CBS News' Ben Tracy on Tuesday asked President Trump how he can be sure the worst of the pandemic is behind us without a vaccine. Mr. Trump responded "tremendous progress has been made" has been made and "this is going to go away," and "whether it comes back in a modified form in the fall, we'll be able to handle it." Watch his answer.
Pentagon agency working on cloning antibodies to fight COVID-19
Researchers for DARPA's Pandemic Prevention Program are trying to come up with a temporary treatment to protect against coronavirus until a vaccine is ready.
Large-scale human trial of potential COVID-19 vaccine kicks off at Oxford
Britain's government is putting more than $50 million toward the race for a coronavirus vaccine, and says "promising projects are making rapid progress."
Novak Djokovic opposes mandatory coronavirus vaccination
"If it becomes compulsory, what will happen? I will have to make a decision," Djokovic said.
Tuberculosis vaccine could be a weapon against coronavirus
Researchers in at least four countries are testing whether the century-old vaccine for tuberculosis can lessen the severity of some COVID-19 cases.
Former FDA commissioner on challenges of reopening the country
Dr. Scott Gottlieb warned there could be a big risk in the fall when schools reopen.
Researchers on the hunt for coronavirus treatments
Experts are testing drugs to see if they can dampen the symptoms caused by COVID-19, including inflammation that ends up damaging the lungs.
What to know about possible coronavirus treatments
Four U.S. biotech companies – Amgen, Genentech, Gilead, and Regeneron – are working on experimental drugs.
Regeneron CSO discusses possible timeline for COVID-19 treatment
"By the end of the summer, we could be treating hundreds of thousands, if not millions of people," Yancopoulos said.
The global race to stop the coronavirus pandemic
Doctors and scientists tell 60 Minutes correspondent Bill Whitaker how their labs are working to blunt the spread of the deadly COVID-19 outbreak.
ICYMI: A look back at Sunday's 60 Minutes
This week on 60 Minutes: Scientists rush to develop a novel coronavirus vaccine, the economic emergency created by coronavirus, and why Hungary is paying its citizens to start families
How scammers are trying to exploit the pandemic
The Justice Department filed its first enforcement action against a website peddling fake vaccines, as CBP seizes counterfeit COVID-19 testing kits.
Inside the race for a vaccine to prevent novel coronavirus
Experts say nationwide restrictions may need to be in place until there is a vaccine to thwart the novel coronavirus. When might that be?
The race to treat or prevent novel coronavirus
The rapid spread of the COVID-19 virus has prompted medical researchers worldwide to go on the offense and look for vaccines and treatments. Bill Whitaker reports on some of the leading efforts.
First patient gets potential coronavirus vaccine
The first person to receive the experimental shot was a 43-year-old mom from Seattle.
New York has 173 cases of coronavirus — among the highest in U.S.
Governor Andrew Cuomo announced that officials are implementing a "containment area" in New Rochelle, the center of the epidemic in New York.
Trump waives tariffs on largest buyers of Russian oil
Oregon school shooter ID'd, used shotgun bought by mother, sources say
Attorneys for Rep. Ilhan Omar accuse DOJ of violating judge's orders
Exclusive
Sacramento mom says hero son shot, killed Oregon school shooter
On economy, Vance says "we're turning the ship around"
Pope Leo discharged from hospital on Saturday, four days after surgery
Live
Reported attacks on ships around Strait of Hormuz reach record highs
Katie Zacharia out as White House press secretary after first week
